Triple-drug tablet approved for HIV infection.
Thompson
C A
CA
D019380:Anti-HIV Agents / Q000627:therapeutic use*; D002626:Chemistry, Pharmaceutical; D015224:Dideoxynucleosides / Q000627:therapeutic use*; D004338:Drug Combinations; D004348:Drug Labeling; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D013607:Tablets; D015215:Zidovudine / Q000627:therapeutic use*; D000099227:Abacavir
D019380:Anti-HIV Agents; D015224:Dideoxynucleosides; D004338:Drug Combinations; D019259:Lamivudine; D013607:Tablets; D015215:Zidovudine; D000099227:Abacavir; C418262:abacavir, lamivudine, and zidovudine drug combination